95092-86-7Relevant academic research and scientific papers
ICT-Isomerization-Induced Turn-On Fluorescence Probe with a Large Emission Shift for Mercury Ion: Application in Combinational Molecular Logic
Bhatta, Sushil Ranjan,Mondal, Bijan,Vijaykumar, Gonela,Thakur, Arunabha
, p. 11577 - 11590 (2017/10/13)
A unique turn-on fluorescent device based on a ferrocene-aminonaphtholate derivative specific for Hg2+ cation was developed. Upon binding with Hg2+ ion, the probe shows a dramatic fluorescence enhancement (the fluorescence quantum yield increases 58-fold) along with a large red shift of 68 nm in the emission spectrum. The fluorescence enhancement with a red shift may be ascribed to the combinational effect of C=N isomerization and an extended intramolecular charge transfer (ICT) mechanism. The response was instantaneous with a detection limit of 2.7 × 10-9 M. Upon Hg2+ recognition, the ferrocene/ferrocenium redox peak was anodically shifted by ΔE1/2 = 72 mV along with a "naked eye" color change from faint yellow to pale orange for this metal cation. Further, upon protonation of the imine nitrogen, the present probe displays a high fluorescence output due to suppression of the C=N isomerization process. Upon deprotonation using strong base, the fluorescence steadily decreases, which indicates that H+ and OH- can be used to regulate the off-on-off fluorescence switching of the present probe. Density functional theory studies revealed that the addition of acid leads to protonation of the imine N (according to natural bond orbital analysis), and the resulting iminium proton forms a strong H-bond (2.307 ?) with one of the triazole N atoms to form a five-membered ring, which makes the molecule rigid; hence, enhancement of the ICT process takes place, thereby leading to a fluorescence enhancement with a red shift. The unprecedented combination of H+, OH-, and Hg2+ ions has been used to generate a molecular system exhibiting the INHIBIT-OR combinational logic operation.
AMINOETHANOL DERIVATIVES
-
Page/Page column 49, (2010/11/30)
The present invention provides a pharmaceutical agent having cholesteryl ester transfer protein inhibitory action and useful as a blood lipid lowering agent and the like. The present invention relates to a compound represented by the formula wherein Ar1 is an aromatic ring group optionally having substituents, Ar2 is an aromatic ring group having substituents, OR'' is an optionally protected hydroxyl group, R is an acyl group, R' is a hydrogen atom or a hydrocarbon group optionally having substituents, or a salt thereof, and a pharmaceutical composition containing a compound of the formula (I) or a salt thereof or a prodrug thereof.
